|
2020
|
Invention
|
Heteroaryl compounds and uses thereof.
The present invention provides compounds, pharmaceuticall... |
|
|
Invention
|
Methods of treating a mk2-mediated disorder. The present invention provides methods of treating, ... |
|
2018
|
Invention
|
Forms and compositions of a mk2 inhibitor. The present invention provides solid forms of an MK2 i... |
|
|
Invention
|
Heteroaryl compounds useful as mk2 inhibitors. The present invention provides compounds, pharmace... |
|
|
Invention
|
Deuterated analogs of mk2 inhibitors and uses thereof. The present invention provides compounds, ... |
|
|
Invention
|
Mk2 inhibitors, synthesis thereof, and intermediates thereto. The present invention provides meth... |
|
|
Invention
|
9,10,11,12-tetrahydro-8h-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one compounds and uses ... |
|
2017
|
Invention
|
Ligand-directed covalent modification of protein. The present invention relates to enzyme inhibit... |
|
2016
|
Invention
|
Methods of treating a disease or disorder associated with bruton's tyrosine kinase.
The present ... |
|
|
Invention
|
Protein kinase conjugates and inhibitors. The invention relates to protein conjugates that contai... |
|
|
Invention
|
Hcv protease inhibitors and uses thereof.
The present invention provides compounds, pharmaceutic... |
|
2015
|
Invention
|
Heteroaryl compounds and uses thereof. The present invention provides compounds, pharmaceutically... |
|
|
Invention
|
Mk2 inhibitors and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Hcv protease inhibitors and uses thereof. The present invention provides compounds, pharmaceutica... |
|
|
Invention
|
Forms and compositions of an erk inhibitor. The present invention provides compounds, composition... |
|
|
Invention
|
Methods of treating a bruton's tyrosine kinase disease or disorder.
The present invention provid... |
|
2013
|
Invention
|
Methods of treating a disease or disorder associated with bruton's tyrosine kinase. The present i... |
|
|
Invention
|
Besylate salt of a btk inhibitor. The present invention provides a salt form, and compositions th... |
|
2012
|
Invention
|
Methods of treating a bruton's tyrosine kinase disease or disorder. The present invention provide... |
|
2010
|
Invention
|
Ligand-directed covalent modification of protein.
The present invention relates to enzyme inhibi... |
|
|
Invention
|
Pi3 kinase inhibitors and uses thereof.
The present invention provides compounds, compositions t... |
|
2009
|
Invention
|
Methods for identifying hcv protease inhibitors. The present invention provides methods for ident... |
